The document discusses the Millennium Development Goals (MDGs) and Sustainable Development Goals (SDGs). It provides details on the 8 MDGs agreed upon in 2000 including goals to eradicate poverty and hunger, achieve universal primary education, promote gender equality, reduce child mortality, improve maternal health, combat HIV/AIDS and other diseases, ensure environmental sustainability, and develop a global partnership. It then discusses the 17 SDGs adopted in 2015 to build upon the MDGs and address additional social and environmental challenges. Key differences between the MDGs and SDGs are described such as the SDGs being more universal in scope and having increased targets, indicators and mechanisms for monitoring progress.
With the deadline for the MDG targets set to expire in 2015, the United Nations and its Member States have embarked on a process to define a future development agenda. UN Secretary General has called for inclusive broad-based consultations within member states on the priorities for the post-2015 development agenda.
To discuss further on how the Corporates could play a proactive role on MDG framework and post 2015 Development agenda Confederation of Indian Industry (CII) in association with UNDP, organizing a half a day workshop on Millennium Development Goals at 0930 hrs on 02 February 2013 in Hyderabad.
ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL (Draft Seminar ...Public Health Update
This is Draft Seminar paper which will present in my class for partial fulfillment of my Syllabus of BPH 8th semester. ''ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL''
Millennium development Goals, MDGs Framework, Millennium development goals, Targets, Indicators, Targets for 2015, India achievement till 2013, National Health Programmes under 12th national Plan (2012- 2017)
UN SDG # 3 : Good Health and Well being
The goal III, aims to address all the major health priorities with regard to child and maternal health, end of communicable diseases, reducing the number of non-communicable diseases cases, ease of access to safe and affordable medicines and vaccines and ensure universal health coverage (UHC), to help build productive and resilient communities. Despite making rapid strides in improving the health and well being through innovation, new drug discoveries and R&D, health care inequality does persist over access. Earlier Millennium Development Goals (MDGs) from 2000-2015, focussed on specific health conditions of maternal and child health, communicable diseases viz; HIV/AIDS, other diseases like Tuberculosis, vector borne diseases like Malaria. What MDGs lacked was focus with regard to entire health system and how they cater to health services for overall health and wellbeing. SDGs 2030 agenda from 2015-2030 , has set the target towards focus on Universal Health Coverage (UHC), which includes access to health services and with financial risk protection.
With the deadline for the MDG targets set to expire in 2015, the United Nations and its Member States have embarked on a process to define a future development agenda. UN Secretary General has called for inclusive broad-based consultations within member states on the priorities for the post-2015 development agenda.
To discuss further on how the Corporates could play a proactive role on MDG framework and post 2015 Development agenda Confederation of Indian Industry (CII) in association with UNDP, organizing a half a day workshop on Millennium Development Goals at 0930 hrs on 02 February 2013 in Hyderabad.
ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL (Draft Seminar ...Public Health Update
This is Draft Seminar paper which will present in my class for partial fulfillment of my Syllabus of BPH 8th semester. ''ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL''
Millennium development Goals, MDGs Framework, Millennium development goals, Targets, Indicators, Targets for 2015, India achievement till 2013, National Health Programmes under 12th national Plan (2012- 2017)
UN SDG # 3 : Good Health and Well being
The goal III, aims to address all the major health priorities with regard to child and maternal health, end of communicable diseases, reducing the number of non-communicable diseases cases, ease of access to safe and affordable medicines and vaccines and ensure universal health coverage (UHC), to help build productive and resilient communities. Despite making rapid strides in improving the health and well being through innovation, new drug discoveries and R&D, health care inequality does persist over access. Earlier Millennium Development Goals (MDGs) from 2000-2015, focussed on specific health conditions of maternal and child health, communicable diseases viz; HIV/AIDS, other diseases like Tuberculosis, vector borne diseases like Malaria. What MDGs lacked was focus with regard to entire health system and how they cater to health services for overall health and wellbeing. SDGs 2030 agenda from 2015-2030 , has set the target towards focus on Universal Health Coverage (UHC), which includes access to health services and with financial risk protection.
Support for proven, effective and affordable priority strategies in controlling the most devastating infectious diseases, including:
Bednets and treatment strategies for rolling back malaria
DOTS (Directly-Observed Treatment, Short-course) for stopping TB.
Childhood vaccinations for reducing deaths from measles and other preventable diseases.
IMCI (Integrated Management of Childhood Illnesses) for addressing diarrhoeal diseases.
HIV prevention strategies such as condom prevention, sex education and STI treatment for reducing the spread of HIV/AIDS.
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...Sara Berlanda
In this slideset, Professor Shabir Madhi, WAidid board member, analyses the trends in global and sub-Saharan Africa under-5 childhood mortality, to then demonstrate the contribution of new childhood vaccines in reducing under-5/neonatal morbidity and mortality by vaccination.
To learn more, visit www.waidid.org!
An Interdisciplinary Perspective on Global Health and the SDGs - Prof. Sir An...LIDC
It is rare that you find an outstanding leader in a particular discipline who has also become as well an international figure in interdisciplinary thinking. Prof Sir Andy Haines is just such a figure.
A former Director of the London School of Hygiene and Tropical Medicine and one of the designers and founders of LIDC about a decade ago, Andy has in recent years developed an international reputation and programme linking our development agenda for global health with the much bigger challenge of sustainability and the threat posed to that by climate change and environmental degradation.
His work has revealed the threats posed to health and well being by environmental change, but has emphasized and identified the positive opportunities, and the co-benefits they can generate.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
2. MDGs
In September 2000, leaders of 189 countries gathered at
the United Nations headquarters and signed the historic
Millennium Declaration, in which they committed to
achieving a set of measurable goals that provide a
framework for development planning for countries around
the world by the target date of 2015.
The Millennium Development Goals (MDGs) are
commonly described as a "roadmap for world
development by 2015”.
4. 1. Eradicate extreme poverty and hunger;
2. Achieve universal primary education;
3. Promote gender equality and empower women;
4. Reduce child mortality;
5. Improve maternal health;
6. Combat HIV/AIDS, malaria, and other diseases;
7. Ensure environmental Sustainability; and
8. Develop a global partnership for development.
5. Goal 4: Reduce Child Mortality Rate
Target 5:
Reduce by two thirds, between 1990 and 2015, the Under-
five mortality rate.
Indicator:
Under-five mortality rate
Infant mortality rate
Proportion of eye year children immunized against
measles.
6. Goal 5: Improve Maternal Health
Target 6:
Reduce by three quarters, between 1990 and 2015, the
maternal mortality ratio.
Indicator:
Maternal mortality ratio
Proportion of births attended by skilled health personnel
7. Goal 6: Combat HIV/AIDS, Malaria
and other Diseases
Target 7:
Have halted by 2015 and begun to reverse the spread
of HIV /AIDS.
Indicator:
HIV prevalence among pregnant women aged 15-24
years
Condom use rate of contraceptive prevalence rate
Condom use at last high-risk Sex
Percentage of population aged 15-24 years with
comprehensive correct knowledge of HIV/AIDS
8. Continue..
Contraceptive prevalence rate
Ratio of School attendance of orphans to School
attendance of non-orphans aged 10- 14 years
Target 8:
Have halted by 2015 and began to reverse the incidence of
malaria and other major diseases.
9. Continue..
Indicator:
Prevalence and death rates associated with malaria
Proportion of population in malaria-risk areas using
effective malaria prevention and
Treatment measures
Prevalence and death rate associated with tuberculosis
Proportion of tuberculosis cases detected and cured under
DOTS.
10. Reasons for MDGs to SDGs
>800 million live on less than $1.25 per day
1 in 9 people is hungry each night
1 in 6 adults is illiterate
Deforestation remains high
Oceans are becoming more acidic, and many more
11. SDGs (2015-2030)
The Sustainable Development Goals (SDGs), officially
known as Transforming our world: the 2030. Agenda for
Sustainable Development, are an intergovernmental set of
aspiration goals. On 19 July 2014, the Open Working
Group of the UN General Assembly proposed for the
SDGs to the Assembly. On 5 December 2014, the UN
General Assembly accepted report which of OWG
proposals. On 25 September 2015, the 193 countries of the
UN
General Assembly adopted the 2030 Development
Agenda.
17. SDG-3( Healthy Health and Well Being)
Reduce the global maternal mortality ratio to below 70/100,000.
Reduce neonatal mortality to below 12/1,000 and U5MR to below
25/1,000.
End the epidemics of AIDS, tuberculosis, malaria, and neglected
tropical diseases and combat hepatitis, water-borne diseases, and other
communicable diseases.
Reduce by one-third premature mortality from non communicable
diseases.
Strengthen the prevention and treatment of substance abuse.
Halve the number of global deaths and injuries from road traffic
accidents (by 2020).
Ensure universal access to sexual and reproductive health-care
services.
Achieve universal health coverage.
Reduce the number of deaths and illnesses from hazardous chemicals
and air, water, and soil pollution and contamination.
18. Continue
Strengthen the implementation of the WHO Framework
Convention on Tobacco Control.
Support the research and development of vaccines and
medicines.
Substantially increase health financing and the
recruitment, development, training, and retention of the
health workforce.
Strengthen early warning, risk reduction, and management
of health risks.
19.
20. Continue differences
MDGs
Mainly developing
countries
Goals-8; Target-18; and
Indicators-48
Means of monitoring was
not defined in advance
SDGs
Universal- for all counties
Goals- 17; Targets-169;
and Indicators- >200
Global architecture for
monitoring
21. Features MDGs SDGs
2000 Target 2015 Remark Target Nepal
IMR (per 1000 live births) 64 36 33 FA 12 21
U5 MR (per 1000 live births) 91 54 38 FA 25 32
Proportion of one year old children 71 >90 >92.8 FA 100% 88%
immunized with measles vaccine (%)
Note: FA for Fully Achieved
Goal-4 (Reduce Child Mortality)
22. Features MDGs SDGs
2000 Target 2015 Remark Target Nepal
MMR (per 100000 live births) 415 213 258 PA 70 148 (2017)
Proportion of birth attained by SBA 11 60 55.6 PA 100% 58%
Note: PA for Partially Achieved
Goal-5 (Improve Maternal Health)
23. HIV/AIDS MDGs SDGs
Features 2000 Target 2015 Remark Target Nepal
HIV prevalence among men and
women aged 15-24 years (percent
0.15 Half
and
reverse
0.03 FA 0 -
Condom use at last high-risk
sexual encounter (15-24 year olds)
71.2 NA 65.8 - 100% -
Percentage of population aged 15-
24 years with comprehensive
knowledge of HIV/AIDS
35.6 45 36.4 PA 100% -
Proportion of population with
advanced HIV infection receiving
antiretroviral combination
therapy (percent)
NA 80% 26.5 - 100% -
Goal-6 (Combat HIV/TB/Malaria
24. Malaria MDGs SDGs
Features 2000 Target 2015 Remark Target Nepal
Clinical malaria incidence (per
1,000 people (percent)
NA Half &
reverse
1.74 - 0 -
Annual parasite incidence (per
1,000 people
0.55 0.06 0.11 PA 0 -
Death rate associated with malaria
(per 1,000 people at risk)
0.55 Half &
Reverse
0 FA 0 -
Percentage of children under five
with fever who are treated with
appropriate anti-malarial drugs
/ Percentage of children under
five who sleep under a long lasting
insecticide treated bed net
3.2/48.2 2.5/100 2.8/
96.8
PA/PA 100%/
100%
-
Goal-6 (Combat HIV/TB/Malaria
25. Tuberculosis MDGs SDGs
Features 2000 Target 2015 Remark Target Nepal
Prevalence rate associated with TB
(per 100000)
310 Half &
reverse
211 FA 0 -
Death rate associated with TB (
per 100000)
023 Half &
Reverse
20 FA 0 -
Proportion of TB cases detected 70 85 83 PA 0 -
Proportion of TB cases cured
under DOTS
89 91 91 FA 100% -
Goal-6 (Combat HIV/TB/Malaria
26. Additional areas of SDGs
Chronic Diseases
Mental Health
Substance use including alcohol use
Road Traffic Accidents
Reproductive and Sexual Health
Health Financing